WHBL Sheboygan |
FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer
FDA.gov FDA expands approval of Zelboraf (vemurafenib) to treat certain adult patients with Erdheim-Chester Disease, a rare cancer of the blood. Release. The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the ... First Tx for Erdheim-Chester Disease, a Rare Blood Cancer FDA approves Roche drug for rare type of blood cancer FDA approves Zelboraf for BRAF V600-mutated Erdheim-Chester disease |
from Health - Google News http://ift.tt/2yaDWsB